Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Health Sciences, Istanbul, Turkey.
Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, University of Health Sciences, Istanbul, Turkey.
Curr Drug Deliv. 2024;21(7):1010-1023. doi: 10.2174/1567201820666230214091509.
The domperidone maleate, a lipophilic agent classified as a Biopharmaceutical Classification System Class II substance with weak water solubility. Self- Emulsifying Drug Delivery System is a novel approach to improve water solubility and, ultimately bioavailability of drugs.
This study aimed to develop and characterize new domperidone-loaded self-emulsifying drug delivery systems as an alternative formulation and to evaluate the permeability of domperidone-loaded self-emulsifying drug delivery systems by using Caco-2 cells and single-pass intestinal perfusion method.
Three self-emulsifying drug delivery systems were prepared and characterized in terms of pH, viscosity, droplet size, zeta potential, polydispersity index, conductivity, . Each formulation underwent 10, 100, 200, and 500 times dilution in intestinal buffer pH 6.8 and stomach buffer pH 1.2, respectively. Female Sprague Dawley rats were employed for single-pass intestinal perfusion investigations.
Results of the study revealed that the ideal self-emulsifying drug delivery systems formulation showed narrow droplet size, ideal zeta potential, and no conductivity. Additionally, as compared to the control groups, the optimum formulation had better apparent permeability (12.74 ± 0.02×10-4) from Caco-2 cell monolayer permeability experiments. The study also revealed greater Peff values (2.122 ± 0.892×10-4 cm/s) for the optimal formulation from intestinal perfusion analyses in comparison to control groups (Domperidone; 0.802 ± 0.418×10-4 cm/s).
To conclude, prepared formulations can be a promising way of oral administration of Biopharmaceutical Classification System Class II drugs.
马来酸多潘立酮是一种亲脂性物质,属于生物药剂学分类系统 II 类物质,水溶性较弱。自乳化药物传递系统是一种提高药物水溶性并最终提高生物利用度的新方法。
本研究旨在开发和表征新的多潘立酮载自乳化药物传递系统作为替代制剂,并通过 Caco-2 细胞和单向肠灌流法评估多潘立酮载自乳化药物传递系统的渗透性。
制备并表征了三种自乳化药物传递系统,分别考察 pH 值、粘度、粒径、Zeta 电位、多分散指数、电导率。每种配方分别在肠缓冲液 pH6.8 和胃缓冲液 pH1.2 中稀释 10、100、200 和 500 倍。采用雌性 Sprague Dawley 大鼠进行单向肠灌流研究。
研究结果表明,理想的自乳化药物传递系统制剂具有较窄的粒径、理想的 Zeta 电位和无电导率。此外,与对照组相比,最佳制剂的 Caco-2 细胞单层渗透性实验具有更好的表观渗透性(12.74±0.02×10-4)。研究还发现,与对照组相比,最佳制剂的 Peff 值(2.122±0.892×10-4cm/s)从肠灌流分析中更高(多潘立酮;0.802±0.418×10-4cm/s)。
总之,所制备的制剂可能是生物药剂学分类系统 II 类药物口服给药的一种有前途的方法。